Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dermatitis, Allergic Contact | 11 | 2022 | 19 | 3.010 |
Why?
|
| Dietary Supplements | 5 | 2023 | 558 | 2.500 |
Why?
|
| Nails | 2 | 2023 | 36 | 1.610 |
Why?
|
| Cosmetics | 4 | 2021 | 17 | 1.310 |
Why?
|
| Skin | 5 | 2022 | 1259 | 1.200 |
Why?
|
| Facial Dermatoses | 3 | 2017 | 26 | 1.160 |
Why?
|
| Dermatitis, Contact | 3 | 2013 | 34 | 1.080 |
Why?
|
| Allergens | 6 | 2019 | 247 | 1.000 |
Why?
|
| Hair | 2 | 2023 | 42 | 0.940 |
Why?
|
| Perfume | 3 | 2021 | 3 | 0.930 |
Why?
|
| Skin Aging | 2 | 2020 | 56 | 0.850 |
Why?
|
| Vitamin A | 1 | 2022 | 94 | 0.820 |
Why?
|
| Prescription Drugs | 1 | 2022 | 64 | 0.800 |
Why?
|
| Whey Proteins | 1 | 2020 | 7 | 0.770 |
Why?
|
| Vitamin B 6 | 1 | 2020 | 19 | 0.770 |
Why?
|
| Testosterone Congeners | 1 | 2020 | 26 | 0.760 |
Why?
|
| Skin Diseases | 3 | 2018 | 349 | 0.760 |
Why?
|
| Acne Vulgaris | 1 | 2020 | 47 | 0.750 |
Why?
|
| Vitamin B 12 | 1 | 2020 | 73 | 0.740 |
Why?
|
| Vitamin B Complex | 1 | 2020 | 51 | 0.740 |
Why?
|
| Iodine | 1 | 2020 | 54 | 0.730 |
Why?
|
| Patch Tests | 7 | 2022 | 12 | 0.680 |
Why?
|
| Hand Dermatoses | 2 | 2017 | 25 | 0.640 |
Why?
|
| Hair Preparations | 1 | 2017 | 1 | 0.630 |
Why?
|
| Nutritional Status | 1 | 2020 | 337 | 0.620 |
Why?
|
| Diet | 3 | 2020 | 1440 | 0.570 |
Why?
|
| Cinnamomum zeylanicum | 1 | 2015 | 2 | 0.540 |
Why?
|
| Product Labeling | 2 | 2021 | 13 | 0.530 |
Why?
|
| Eyelids | 1 | 2015 | 163 | 0.480 |
Why?
|
| Anti-Infective Agents | 1 | 2017 | 446 | 0.460 |
Why?
|
| Thiazoles | 1 | 2017 | 726 | 0.450 |
Why?
|
| Nutrition Surveys | 2 | 2023 | 295 | 0.390 |
Why?
|
| Melanosis | 1 | 2010 | 16 | 0.380 |
Why?
|
| Mouth Diseases | 1 | 2010 | 34 | 0.380 |
Why?
|
| Nail Diseases | 1 | 2010 | 40 | 0.380 |
Why?
|
| Resins, Plant | 1 | 2009 | 3 | 0.370 |
Why?
|
| Minerals | 1 | 2010 | 71 | 0.360 |
Why?
|
| Hallux | 1 | 2008 | 3 | 0.330 |
Why?
|
| Neomycin | 1 | 2008 | 38 | 0.320 |
Why?
|
| Foot Diseases | 1 | 2008 | 52 | 0.320 |
Why?
|
| Cefuroxime | 1 | 2007 | 15 | 0.310 |
Why?
|
| Serum Sickness | 1 | 2007 | 5 | 0.310 |
Why?
|
| Dermatitis, Occupational | 2 | 2009 | 4 | 0.290 |
Why?
|
| Mite Infestations | 1 | 2005 | 5 | 0.270 |
Why?
|
| Humans | 37 | 2023 | 261506 | 0.270 |
Why?
|
| Dermatomycoses | 1 | 2005 | 42 | 0.260 |
Why?
|
| Propylene Glycol | 1 | 2005 | 10 | 0.260 |
Why?
|
| Rodentia | 1 | 2005 | 65 | 0.260 |
Why?
|
| Iatrogenic Disease | 1 | 2005 | 183 | 0.240 |
Why?
|
| Opportunistic Infections | 1 | 2005 | 223 | 0.240 |
Why?
|
| Hemosiderosis | 1 | 2003 | 14 | 0.230 |
Why?
|
| Research Personnel | 1 | 2005 | 156 | 0.230 |
Why?
|
| Scalp | 1 | 2005 | 156 | 0.230 |
Why?
|
| Periodicity | 1 | 2003 | 68 | 0.230 |
Why?
|
| Skin Diseases, Infectious | 1 | 2003 | 22 | 0.230 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 4314 | 0.220 |
Why?
|
| Erythema Infectiosum | 1 | 2002 | 11 | 0.220 |
Why?
|
| Cryosurgery | 2 | 2023 | 167 | 0.220 |
Why?
|
| Disease Outbreaks | 1 | 2005 | 415 | 0.210 |
Why?
|
| Parvovirus B19, Human | 1 | 2002 | 39 | 0.210 |
Why?
|
| Parvoviridae Infections | 1 | 2002 | 38 | 0.210 |
Why?
|
| Anti-Bacterial Agents | 3 | 2012 | 2992 | 0.210 |
Why?
|
| Marketing | 1 | 2021 | 18 | 0.200 |
Why?
|
| Hemangioma | 1 | 2003 | 154 | 0.200 |
Why?
|
| Odorants | 1 | 2021 | 73 | 0.200 |
Why?
|
| Comprehension | 1 | 2022 | 120 | 0.200 |
Why?
|
| Sarcoidosis | 1 | 2002 | 112 | 0.190 |
Why?
|
| Skin Neoplasms | 3 | 2008 | 4654 | 0.190 |
Why?
|
| United States Food and Drug Administration | 1 | 2022 | 332 | 0.190 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 1209 | 0.180 |
Why?
|
| Skin Diseases, Bacterial | 2 | 2012 | 44 | 0.180 |
Why?
|
| Textiles | 2 | 2010 | 10 | 0.180 |
Why?
|
| Drug and Narcotic Control | 1 | 2019 | 31 | 0.180 |
Why?
|
| Glycosylation | 1 | 2020 | 213 | 0.180 |
Why?
|
| Pregnancy | 2 | 2023 | 7573 | 0.180 |
Why?
|
| Drug Contamination | 1 | 2019 | 52 | 0.170 |
Why?
|
| Female | 15 | 2023 | 141928 | 0.170 |
Why?
|
| Health Status | 1 | 2022 | 590 | 0.160 |
Why?
|
| Surgical Flaps | 1 | 2005 | 927 | 0.160 |
Why?
|
| Rosacea | 1 | 2018 | 16 | 0.160 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 717 | 0.160 |
Why?
|
| Drug Interactions | 1 | 2019 | 553 | 0.160 |
Why?
|
| Dermatitis, Atopic | 1 | 2018 | 47 | 0.150 |
Why?
|
| Diagnosis, Differential | 4 | 2010 | 4744 | 0.150 |
Why?
|
| Psoriasis | 1 | 2018 | 126 | 0.150 |
Why?
|
| Male | 11 | 2023 | 123000 | 0.130 |
Why?
|
| Adult | 6 | 2023 | 77950 | 0.120 |
Why?
|
| Administration, Topical | 2 | 2019 | 257 | 0.120 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 1085 | 0.120 |
Why?
|
| Mycobacterium marinum | 1 | 2012 | 8 | 0.110 |
Why?
|
| Aged | 6 | 2023 | 70117 | 0.100 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2012 | 82 | 0.100 |
Why?
|
| Lip Diseases | 1 | 2010 | 4 | 0.100 |
Why?
|
| Complementary Therapies | 1 | 2012 | 126 | 0.100 |
Why?
|
| Melanoma | 1 | 2008 | 5317 | 0.100 |
Why?
|
| Leg | 1 | 2012 | 226 | 0.100 |
Why?
|
| Intestinal Polyposis | 1 | 2010 | 30 | 0.100 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2010 | 56 | 0.100 |
Why?
|
| Patient Education as Topic | 2 | 2008 | 748 | 0.090 |
Why?
|
| Middle Aged | 7 | 2023 | 86204 | 0.090 |
Why?
|
| Formaldehyde | 1 | 2010 | 114 | 0.090 |
Why?
|
| Mouth Mucosa | 1 | 2010 | 216 | 0.090 |
Why?
|
| Infant | 2 | 2021 | 13310 | 0.090 |
Why?
|
| Inflammation | 1 | 2020 | 2522 | 0.090 |
Why?
|
| Head and Neck Neoplasms | 1 | 2005 | 3976 | 0.090 |
Why?
|
| Dermatitis, Irritant | 1 | 2009 | 6 | 0.090 |
Why?
|
| Plants | 1 | 2009 | 62 | 0.080 |
Why?
|
| Parabens | 1 | 2008 | 5 | 0.080 |
Why?
|
| Gloves, Protective | 1 | 2008 | 8 | 0.080 |
Why?
|
| Nickel | 1 | 2008 | 44 | 0.080 |
Why?
|
| Plant Preparations | 1 | 2008 | 36 | 0.080 |
Why?
|
| Mastitis | 1 | 2007 | 12 | 0.080 |
Why?
|
| Syndrome | 1 | 2010 | 1351 | 0.080 |
Why?
|
| Pruritus | 1 | 2007 | 87 | 0.070 |
Why?
|
| Arthralgia | 1 | 2007 | 89 | 0.070 |
Why?
|
| United States | 2 | 2022 | 15433 | 0.070 |
Why?
|
| Gold | 1 | 2008 | 270 | 0.070 |
Why?
|
| Pharmaceutical Vehicles | 1 | 2005 | 15 | 0.070 |
Why?
|
| Laboratory Animal Science | 1 | 2005 | 24 | 0.070 |
Why?
|
| Ointments | 1 | 2005 | 27 | 0.060 |
Why?
|
| Keratosis | 1 | 2005 | 39 | 0.060 |
Why?
|
| Exanthema | 1 | 2007 | 211 | 0.060 |
Why?
|
| Fever | 1 | 2007 | 497 | 0.060 |
Why?
|
| Diltiazem | 1 | 2003 | 12 | 0.060 |
Why?
|
| Photosensitivity Disorders | 1 | 2003 | 23 | 0.060 |
Why?
|
| Hyperpigmentation | 1 | 2003 | 32 | 0.060 |
Why?
|
| Calcium Channel Blockers | 1 | 2003 | 135 | 0.060 |
Why?
|
| Linezolid | 1 | 2003 | 64 | 0.060 |
Why?
|
| Menstrual Cycle | 1 | 2003 | 56 | 0.060 |
Why?
|
| Oxazolidinones | 1 | 2003 | 60 | 0.060 |
Why?
|
| Nevus, Pigmented | 1 | 2003 | 104 | 0.050 |
Why?
|
| Methicillin Resistance | 1 | 2003 | 147 | 0.050 |
Why?
|
| Drug Resistance, Multiple | 1 | 2003 | 204 | 0.050 |
Why?
|
| Acetamides | 1 | 2003 | 113 | 0.050 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2005 | 272 | 0.050 |
Why?
|
| Sarcoma, Kaposi | 1 | 2003 | 187 | 0.050 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2008 | 1415 | 0.050 |
Why?
|
| Health Resources | 1 | 2022 | 168 | 0.050 |
Why?
|
| Cicatrix | 1 | 2002 | 208 | 0.040 |
Why?
|
| Clothing | 2 | 2010 | 26 | 0.040 |
Why?
|
| Animals | 2 | 2020 | 59536 | 0.040 |
Why?
|
| Time Factors | 1 | 2013 | 12926 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 15694 | 0.040 |
Why?
|
| Mastectomy, Segmental | 1 | 2023 | 1026 | 0.040 |
Why?
|
| Staphylococcal Infections | 1 | 2003 | 672 | 0.040 |
Why?
|
| Internet | 1 | 2022 | 706 | 0.040 |
Why?
|
| Mastectomy | 1 | 2023 | 1534 | 0.040 |
Why?
|
| Recurrence | 1 | 2005 | 4758 | 0.040 |
Why?
|
| Rats | 1 | 2005 | 6086 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2023 | 1162 | 0.030 |
Why?
|
| Texas | 1 | 2005 | 6311 | 0.030 |
Why?
|
| Medicine, Ayurvedic | 1 | 2012 | 5 | 0.030 |
Why?
|
| Homeopathy | 1 | 2012 | 9 | 0.030 |
Why?
|
| Child | 2 | 2005 | 29154 | 0.030 |
Why?
|
| Medicine, Chinese Traditional | 1 | 2012 | 30 | 0.030 |
Why?
|
| Hypnosis | 1 | 2012 | 14 | 0.030 |
Why?
|
| Biofeedback, Psychology | 1 | 2012 | 49 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2009 | 14889 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 2218 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 29902 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2005 | 16273 | 0.020 |
Why?
|
| Household Products | 1 | 2008 | 2 | 0.020 |
Why?
|
| Latex Hypersensitivity | 1 | 2008 | 2 | 0.020 |
Why?
|
| Elastomers | 1 | 2008 | 4 | 0.020 |
Why?
|
| Adhesives | 1 | 2008 | 12 | 0.020 |
Why?
|
| Quality of Life | 1 | 2022 | 4532 | 0.020 |
Why?
|
| Metals | 1 | 2008 | 155 | 0.020 |
Why?
|
| Immunization | 1 | 2009 | 397 | 0.020 |
Why?
|
| Pharmaceutical Preparations | 1 | 2008 | 152 | 0.020 |
Why?
|
| Adolescent | 1 | 2005 | 31252 | 0.020 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2008 | 598 | 0.010 |
Why?
|
| Incidence | 1 | 2009 | 5673 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 4320 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2009 | 6869 | 0.010 |
Why?
|
| Hypertension | 1 | 2003 | 1503 | 0.010 |
Why?
|
| Biopsy | 1 | 2002 | 3443 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2012 | 32848 | 0.010 |
Why?
|